CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer

<div>The level of expression of CLDN4 in OC in our cohort and the diagnostic value of this gene. (a) RT-PCR to analyze the expression of CLDN4 in OC and nontumor specimens. (b) The diagnostic usefulness of CLDN4 expression in screening OC specimens and differentiating them from nontumor specimens was validated by ROC analysis.</div>

Mediators of Inflammation

fig8

Figure 8

Figure 8: CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer 